Skip to main content
Clinical Trials/KCT0006270
KCT0006270
Recruiting
未知

Establishment of comprehensive geriatric assessment based multidisciplinary teamapproach for hospitalized frail patients

Seoul National University Bundang Hospital0 sites1,040 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Sponsor
Seoul National University Bundang Hospital
Enrollment
1040
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients 65 years of age or older who are hospitalized or scheduled to be hospitalized due to acute illness.
  • 2\. Patients categorized to Frail or Prefrail assessed by Korean version of the Fatigue, Resilience, Ambulation, Illness and Loss of Weight scale (K\-FRAIL)
  • 3\. Patients having two or more of the following diseases (hypertension, diabetes, ischemic heart disease, chronic lung disease, arthritis, stroke, depression, chronic kidney disease, dementia)
  • 4\. Patient who are living at home for more than 3 months before hospitalisation.
  • 5\. (For substudy 3 only) Patients who subject to conventional primary chemotherapy because local treatment for curative purposes (such as surgery, concurrent chemoradiotherapy, radiation therapy, etc.) is ineligible (stage stage 3 or higher)
  • 6\. (For substudy 3 only) Patients confirmed histologically as cancer (gastric adenocarcinoma, colon adenocarcinoma, non\-small cell and small cell lung cancer, pancreatic adenocarcinoma, biliary adenocarcinoma)

Exclusion Criteria

  • 1\. Patients who planned hospitalisation in the specialised care unit, such as an intensive care unit and/or acute stroke ward, at the time of admission
  • 2\. Patients whose stage is terminal requiring hospice or palliative care.
  • 3\. Life expectancy is less than 6 months
  • 4\. Serious conditions that limit the participation in the research
  • 5\. (For substudy 3 only) Patients who planned to use oral targeted therapy as a palliative first\-line chemotherapy
  • 6\. (For substudy 3 only)) Patients who recur within 6 months after completion of adjuvant chemotherapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials